Cargando…
Procalcitonin for Diagnostics and Treatment Decisions in Pediatric Lower Respiratory Tract Infections
Mortality and morbidity remain high in pediatric lower respiratory tract infections (LRTIs) despite progress in research and implementation of global diagnostic and treatment strategies in the last decade. Still, 120 million annual episodes of pneumonia affect children younger than 5 years each year...
Autores principales: | Baumann, Philipp, Baer, Gurli, Bonhoeffer, Jessica, Fuchs, Aline, Gotta, Verena, Heininger, Ulrich, Ritz, Nicole, Szinnai, Gabor, Bonhoeffer, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581362/ https://www.ncbi.nlm.nih.gov/pubmed/28894729 http://dx.doi.org/10.3389/fped.2017.00183 |
Ejemplares similares
-
Drivers of antibiotic prescribing in children and adolescents with febrile lower respiratory tract infections
por: Gotta, Verena, et al.
Publicado: (2017) -
The kinetic profiles of copeptin and mid regional proadrenomedullin (MR-proADM) in pediatric lower respiratory tract infections
por: Baumann, Philipp, et al.
Publicado: (2022) -
Procalcitonin Guidance to Reduce Antibiotic Treatment of Lower Respiratory Tract Infection in Children and Adolescents (ProPAED): A Randomized Controlled Trial
por: Baer, Gurli, et al.
Publicado: (2013) -
Long-Term Outcomes of Acute Osteoarticular Infections in Children
por: Manz, Nora, et al.
Publicado: (2020) -
Risk Factors for Indeterminate Interferon-Gamma Release Assay for the Diagnosis of Tuberculosis in Children—A Systematic Review and Meta-Analysis
por: Meier, Noëmi R., et al.
Publicado: (2019)